MIM
ABBV icon

MTM Investment Management’s AbbVie ABBV Stock Holding History

MTM Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
5,539
+2
+0% +$430 0.4% 65
2026
Q1 		$1.2M Sell
5,537
-22
-0.4% -$4.88K 0.38% 68
2025
Q4 		$1.27M Buy
5,559
+1
+0% +$228 0.41% 64
2025
Q3 		$1.29M Sell
5,558
-438
-7% -$89.2K 0.41% 64
2025
Q2 		$1.11M Buy
5,996
+1,252
+26% +$233K 0.37% 70
2025
Q1 		$978K Buy
4,744
+2
+0% +$389 0.38% 74
2024
Q4 		$843K Buy
4,742
+3
+0.1% +$552 0.32% 79
2024
Q3 		$921K Buy
4,739
+4
+0.1% +$747 0.36% 73
2024
Q2 		$812K Sell
4,735
-19
-0.4% -$3.15K 0.33% 78
2024
Q1 		$866K Buy
4,754
+24
+0.5% +$4.14K 0.36% 74
2023
Q4 		$733K Buy
4,730
+2
+0% +$292 0.34% 75
2023
Q3 		$705K Buy
4,728
+2
+0% +$294 0.36% 76
2023
Q2 		$637K Buy
4,726
+2
+0% +$293 0.31% 88
2023
Q1 		$753K Sell
4,724
-4
-0.1% -$612 0.39% 75
2022
Q4 		$764K Sell
4,728
-120
-2% -$18.4K 0.4% 73
2022
Q3 		$651K Buy
4,848
+19
+0.4% +$2.73K 0.37% 77
2022
Q2 		$743K Sell
4,829
-682
-12% -$104K 0.4% 73
2022
Q1 		$893K Buy
5,511
+2
+0% +$291 0.43% 67
2021
Q4 		$746K Sell
5,509
-198
-3% -$23.4K 0.35% 82
2021
Q3 		$616K Sell
5,707
-62
-1% -$7.08K 0.33% 87
2021
Q2 		$650K Buy
5,769
+2
+0% +$225 0.34% 84
2021
Q1 		$624K Buy
5,767
+803
+16% +$85.9K 0.35% 81
2020
Q4 		$532K Buy
+4,964
New +$477K 0.33% 83

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MTM Investment Management's ABBV Position: Q2 2026 in Review

MTM Investment Management increased its AbbVie (ABBV) stake by 0.04% in Q2 2026, buying an estimated $430 and bringing the position to 5,539 shares worth $1.39M. The position accounts for 0.4% of the portfolio, ranked #65.

MTM Investment Management first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MTM Investment Management held 5,539 shares of AbbVie worth $1.39M as of Q2 2026.
  • MTM Investment Management bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.4% of MTM Investment Management's portfolio in Q2 2026, its #65 holding.
  • MTM Investment Management first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.